首页> 外文期刊>Global Pediatric Health >The Impact of Multiple Risk Factors for Venous Thromboembolism and Its Implications for Management
【24h】

The Impact of Multiple Risk Factors for Venous Thromboembolism and Its Implications for Management

机译:多种危险因素对静脉血栓栓塞的影响及其对管理的影响

获取原文
           

摘要

Venous thromboembolism (VTE) is a rare multifactorial disorder in childhood with an annual incidence of about 0.07 to 0.14 per 10 000 children. A 15-year-old female with a body mass index of 48 kg/m2 who endorsed oral contraceptive use presented with clinical findings consistent with deep venous thrombosis along with the presence of a pulmonary embolism. Further workup revealed that the patient was heterozygous for factor V Leiden and homozygous for prothrombin G20210A mutations. There are no current pediatric guidelines for the antithrombotic management of patients with multiple risk factors for VTE. Two such risk factors, obesity and the use of estrogen-containing hormone contraceptives, have been implicated in adult VTE cases but have not been clearly delineated in pediatric patients. The need for guidance regarding the VTE management of these patients has become more apparent given the increasing incidence of childhood obesity and the number of adolescents using oral contraceptives. Additionally, thrombophilia testing remains controversial though testing may be indicated in asymptomatic first-degree relatives and in families with antithrombin, protein C, or protein S deficiencies. Given the increased incidence of multiple risk factors for VTE, there is also a need to develop a comprehensive risk assessment tool for pediatric patients at high risk of VTE.
机译:静脉血栓栓塞(VTE)是儿童时期罕见的多学会障碍,每10 000名儿童的年发病率约为0.07至0.14。一个15岁的女性,体重指数为48公斤/平方米,患有口腔避孕药的临床调查结果与深静脉血栓形成一致,随着肺栓塞的存在。进一步的工作表明,患者对因子V leiden和纯合的丙菌蛋白G20210A突变的杂合。 vteb患者的患者抗血栓性管理没有目前的儿科准则。两种这种危险因素,肥胖症和含雌激素的激素避孕药的使用涉及成年VTE病例,但在儿科患者中尚未明确划定。考虑到儿童肥胖的发病率和使用口服避孕药的青少年的数量增加,对这些患者的VTE管理有关这些患者的VTE管理的需求变得更加明显。另外,血栓形成测试仍然存在争议,尽管可以在无症状的一级亲属和抗凝血酶,蛋白C或蛋白质S缺陷中在患有无症状的一级亲属和家族中表明。鉴于VTE的多种风险因素的发病程度增加,还需要为vteb的高风险开发儿科患者的全面风险评估工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号